The prognostic value of PD-L1 positivity in other malignancies, however, is inconsistent: Most studies reveal a worse outcome correlation [17,21,23,24], whereas favorable outcome has been observed in PD-L1 positive cancers in melanoma and colon cancer [25,26]. This evidence concerns the gene CD274 and cancer.